Polychain Capital
Back to Research Reports
Research Reports

Real world assets: a sector deep dive

Tokenized treasuries and private credit have grown quickly. We size the market, examine the value accrual, and name the risks honestly.

Polychain Research Desk10 min read

Tokenized treasuries were the entry point because the underlying instrument is simple and the buyer already exists: crypto-native balance sheets that want yield without leaving the on-chain environment.

Market sizing

Growth has been fast in percentage terms and still small in absolute terms relative to the traditional market. We model adoption as a function of on-chain treasury balances rather than total fund assets, which produces a more conservative picture than most sell-side estimates.

Value accrual

Fee take rates on tokenized cash instruments are thin and getting thinner. The durable business is distribution and servicing, not issuance. We prefer exposure to the platforms that own the customer over the ones that own the wrapper.

Named risks

Every position in this theme carries the following, and we underwrite each one explicitly.

  • Legal enforceability of the off-chain claim
  • Redemption mechanics under stress
  • Concentration in a single issuer or servicer
  • Smart contract risk on the transfer agent layer
RWA
Tokenization
Private credit

Get Polychain Insights in your inbox

Weekly market analysis, research summaries and portfolio commentary from our desk. No sales pitch, unsubscribe anytime.

We send one email a week and never share your address.

More from this section

July 6, 20268 min read

Q3 2026 market outlook

Our quarterly view on macro conditions, digital asset flows and positioning, including the specific developments that would change our mind.

Read the note
June 5, 20266 min read

Portfolio commentary: June 2026

Monthly attribution across our strategies, including the trades that did not work and what we changed as a result.

Read the note

Want this applied to a mandate?

Book a 30 minute call with an investment specialist and we will walk through how this affects a portfolio like yours.